Sales for this month
July 2026Fiscal year ending March 2027NJSS MRR for July was ¥343,357 thousand, up 18.7% year on year. MRR consists of subscription revenue and recurring revenue and excludes initial fees, additional purchase fees and consulting fees.
The rules for monthly disclosures are not stated.
Month April / Value ¥278,041 thousand, Month May / Value ¥281,828 thousand, Month June / Value ¥286,637 thousand, Month July / Value ¥289,284 thousand, Month August / Value ¥292,462 thousand, Month September / Value ¥295,275 thousand, Month October / Value ¥299,280 thousand, Month November / Value ¥302,811 thousand, Month December / Value ¥306,790 thousand, Month January / Value ¥310,816 thousand, Month February / Value ¥315,329 thousand, Month March / Value ¥319,651 thousand
Scope of aggregation: NJSS (monthly information)
| Item | Details |
|---|---|
| Month Covered | July 2026 |
| Fiscal Year Covered | Fiscal year ending March 2027 |
| Scope of aggregation | NJSS (monthly information) |
| Key KPIs | Indicator name MRR(NJSS) / Value ¥343,357 thousand / Year on year 18.7% |
| Monthly Commentary | NJSS MRR for July was ¥343,357 thousand, up 18.7% year on year. MRR consists of subscription revenue and recurring revenue and excludes initial fees, additional purchase fees and consulting fees. |
| Monthly trend for the same period last year | Month April / Value ¥278,041 thousand, Month May / Value ¥281,828 thousand, Month June / Value ¥286,637 thousand, Month July / Value ¥289,284 thousand, Month August / Value ¥292,462 thousand, Month September / Value ¥295,275 thousand, Month October / Value ¥299,280 thousand, Month November / Value ¥302,811 thousand, Month December / Value ¥306,790 thousand, Month January / Value ¥310,816 thousand, Month February / Value ¥315,329 thousand, Month March / Value ¥319,651 thousand |
| Next Scheduled Disclosure | The rules for monthly disclosures are not stated. |
Items this document does not state (15)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.No reason was provided for the increase in MRR.